Trends in bHCG levels after medication abortion, a novel implant removal device, trends in IUD self-removal during the COVID-19 pandemic, and support for the patient-centeredness of telehealth birth control and abortion care.
Pain management for medication abortion, support for eight years of use for a LNG 52mg IUD (Mirena and Liletta), IUD placement within 48 hours after medication abortion, and more.
Ketamine versus fentanyl for pain management during abortion procedures, three studies supporting telehealth, evidence that people can correctly and consistently use progestin-only pills, and more.
Management of retained products of conception and a comparison of buccal and vaginal misoprostol for medication abortion, contraceptive values and preferences of adolescents and young adults, and more.
Effective emergency contraception for individuals with obesity, the need for a reproductive justice lens in contraceptive counseling, a new treatment for bacterial vaginosis, and more.
Zinc supplements to help clear cervical HPV, unmet needs for reproductive health care in primary care settings, distance related barriers to abortion access, and more.
Substantial support for over-the-counter abortion medication, benefits and risks of immediate post partum IUD and implant insertions, expanding access to the full range of emergency contraceptive options, and more.
Benefits of increasing single-visit access to contraception, Black women’s experience with racism in reproductive health care in the U.S., the relationship between contraceptive satisfaction and sexual well-being, and more.
